Bull sharks linger in warming Sydney waters
The predators are migratory, swimming north in winter when Sydney's long-term ocean temperatures dip below 19 degrees Celsius (66 degrees Fahrenheit) to bask in the balmier waters off Queensland.
A team of scientists looked at 15 years of acoustic tracking of 92 tagged migratory sharks in an area including Bondi Beach and Sydney Harbour.
Records show the sharks now spend an average of 15 days longer off Sydney's coast in summer than they did in 2009, said James Cook University researcher Nicolas Lubitz.
"If they're staying longer, it means that people and prey animals have a longer window of overlap with them."
Shark attacks are rare in ocean-loving Australia, and most serious bites are from three species: bull sharks, great whites, and tiger sharks, according to a national database.
There have been more than 1,200 shark incidents around Australia since 1791, of which over 250 resulted in death.
Researchers found an average warming of 0.57C in Bondi for the October-May period between 2006 and 2024, said the study published in the peer-reviewed journal Science of The Total Environment.
Over a longer period, remotely sensed summer sea-surface temperatures in the area rose an average 0.67C between 1982 and 2024, they said.
- Bull sharks 'year-round' -
"If this trend persists, which it likely will, it just means that these animals are going to spend more and more time towards their seasonal distributional limit, which currently is southern and central New South Wales," Lubitz said.
"So it could be that a few decades from now, maybe bull sharks are present year-round in waters off Sydney," he added.
"While the chances of a shark bite, and shark bites in Australia in general, remain low, it just means that people have to be more aware of an increased window of bull shark presence in coastal waters off Sydney."
Climate change could also change breeding patterns, Lubitz said, with early evidence indicating juvenile sharks were appearing in rivers further south.
There was some evidence as well that summer habitats for great whites, which prefer colder waters, were decreasing in northern New South Wales and Queensland, he said.
Tagged sharks trigger an alarm when they swim within range of a network of receivers dotted around parts of the Australian coast, giving people real-time warnings on a mobile app of their presence at key locations.
djw/hmn
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Disturbing discovery on remote Aussie island 'paints a concerning picture'
Scientists have made a worrying discovery on a remote Australian island located 4,100 kilometres southwest of Perth. In just three generations, Heard Island has lost a quarter of its glaciers due to climate change. Monash University reported on the findings on Monday, warning the melting that occurred on the sub-Antarctic island will have 'devastating consequences' for its biodiversity. Heard Island is just 368 square kilometres, and along with the nearby McDonald Island, it provides critical breeding grounds for seabirds and is home to 29 mammal species, including elephant seals. Because Heard Island is so remote, it has been understudied. When topographical maps from 1947 were compared with satellite imagery from 1988 and 2019, it was clear that 23.1 per cent of the icy cryosphere no longer existed. Retreat of sea ice labelled 'profound' Dr Levan Tielidze, a SAEF Research Fellow in the Monash School of Earth, Atmosphere and Environment, said Heard Island had 'suffered profound consequences from climate warming' despite it being in a remote location. 'The island's location in the Southern Ocean makes it a key part of the global climate system and an important indicator of the planet's health, so the changes we are observing paint a really clear and concerning picture,' he said. The team now plan to further their investigation into the retreating glaciers and the resulting impact on wildlife by visiting the island. They will then use computer modelling to further understand how the island will change. Can we stop the sea ice retreat? The Head of Monash School of Earth, Atmosphere and Environment, Professor Andrew Mackintosh, said further loss of ice is 'unavoidable' 'Whether we retain glaciers or lose most of them entirely is up to humans and the greenhouse gas emission pathway we follow,' he said. 'It might also mean the difference between a future where biodiversity is devastated, or one where key parts are secured.' ☠️Alarm raised after strange backyard phenomenon worsens in tropical region 🌳 New $48 million national park announced 😳 Incredible discovery at market after common fish purchase The research has been published in the journal European Geosciences Union. Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.
Yahoo
2 hours ago
- Yahoo
Deep-sea creatures are interconnected across globe via hidden ocean ‘superhighway'
Marine animals living in the cold, dark depths of the ocean are interconnected across the world by a hidden 'superhighway', a groundbreaking new study suggests. The research, published in the journal Nature, provides a detailed global map of marine creatures closely related to starfish called brittle stars. Researchers at Australia's Museums Victoria Research Institute assessed how these spiny creatures occupied every ocean, from tropical shallows to icy depths stretching from the equator to the polar regions. They analysed DNA from nearly 2,700 brittle star specimens taken during hundreds of research expeditions and housed in 48 natural history museums worldwide and found that these creatures had crossed entire oceans over millions of years. The gradual migration of these deep-sea creatures led to invisible links forming between ecosystems as far apart as Iceland and Tasmania, they found. Brittle stars have lived for over 480 million years and come to occupy all ocean floors, including at depths of over 3,500 meters. 'You might think of the deep sea as remote and isolated, but for many animals on the seafloor, it is actually a connected superhighway,' Tim O'Hara, lead author of the study, said. 'Over long timescales, deep-sea species have expanded their ranges by thousands of kilometres. This connectivity is a global phenomenon that's gone unnoticed, until now.' The study also examines the critical role played by these creatures in marine ecosystems across all the oceans. While life forms in shallow waters are restricted by temperature boundaries, the deep-sea environments are more stable, allowing species to disperse over vast distances. In such environments, brittle stars produce yolk-rich larvae that drift on currents for extended periods, giving them the ability to colonise far-flung regions. 'These animals don't have fins or wings, but they've still managed to span entire oceans. The secret lies in their biology,' according to Dr O'Hara, 'their larvae can survive for a long time in cold water, hitching a ride on slow-moving deep-sea currents.' Deep-sea ecosystems are more closely related across regions than their shallow-water counterparts. Marine animals off southern Australia, for instance, share close evolutionary links with species in the North Atlantic, on the other side of the planet. 'A close relationship exists between deep-sea faunas of the northern Atlantic and, on the opposite side of the globe, southern Australia,' researchers said. But extinction events, environmental change and geography have over the millennia created a patchwork of biodiversity across the seafloor. 'It's a paradox,' Dr O'Hara explained. 'The deep sea is highly connected, but also incredibly fragile. Understanding how life is distributed and moves through this vast environment is essential if we want to protect it, especially as threats from deep-sea mining and climate change increase.'
Yahoo
2 hours ago
- Yahoo
Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ABT-301, enabling the initiation of a Phase 1/2 clinical trial in combination with tislelizumab and bevacizumab for patients with metastatic colorectal cancer (mCRC). This open-label, multi-center international study plans to enroll 66 patients with proficient mismatch repair (pMMR) or non-microsatellite instability-high (non-MSI-H) mCRC to evaluate the safety and preliminary efficacy of the triplet therapy. Enrollment is planned in Taiwan and Australia. Tislelizumab, a PD-1 monoclonal antibody, used in this trial is provided by BeOne Medicines (formerly known as BeiGene). Further details on this collaboration were disclosed by Anbogen in a press release dated September 27, 2024. ABT-301 is an oral HDAC1/2/3 inhibitor. Preclinical studies have shown that it promotes CD8+ cytotoxic T cell infiltration and activity, enhances antigen presentation, and inhibits M-MDSCs cells, effectively modulating the tumor microenvironment and converting "cold tumors" into "hot tumors" to improve the efficacy of immune checkpoint inhibitors. ABT-301 also exhibits pro-apoptotic, anti-angiogenic, and tumor metabolic regulation effects. As a single-molecule, multi-modality anti-cancer agent, ABT-301 aims to enhance tumor treatment when combined with the two antibody drugs. Notably, in a previous Phase 1 monotherapy clinical trial involving 23 participants, ABT-301 did not exhibit neutropenia or cardiac toxicity, which are commonly observed in other HDAC inhibitors—further supporting its suitability for use in combination immunotherapy. Approximately 95% of mCRC patients are pMMR or non-MSI-H types—commonly referred to as "cold tumors"—which respond poorly to current immunotherapies. Only around 5% of patients with deficient mismatch repair (dMMR) or microsatellite instability-high (MSI-H) "hot tumors" typically benefit from immune checkpoint inhibitors. According to GlobalData, an estimated 370,000 new pMMR/non-MSI-H patients in second-line or later settings are diagnosed annually across the U.S., China, Japan, and the top five European markets (UK, France, Germany, Spain, and Italy), representing a potential market size of USD $9 billion. Anbogen stated that the FDA's IND approval marks a key milestone in the development of ABT-301, demonstrating the safety profile of the triplet therapy and advancing it into clinical stages. The company emphasized that the study targets the majority of patients (over 90%) with poor responses to immunotherapy, aiming to provide a novel treatment option and address this unmet clinical need. Looking ahead, Anbogen will continue to advance the clinical development of ABT-301 while pursuing global licensing and strategic partnerships to accelerate commercialization and market entry. The company is also launching its Series B fundraising to attract strategic partners committed to advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics Anbogen Therapeutics is a clinical-stage biotechnology company committed to developing precision oncology therapies that improve the lives of cancer patients worldwide. The company currently has two core assets: ABT-301, a HDAC1/2/3 inhibitor with immune-modulating capabilities, enhances the tumor microenvironment and boosts immune responses. It significantly improves the efficacy of immune checkpoint inhibitors (ICIs) in metastatic colorectal cancer (mCRC), offering a new treatment pathway for the majority of patients who do not benefit from ICIs. ABT-501 is a novel Peptide Drug Conjugate (PDC) that targets LHRH-receptor tumors using a proprietary delivery system. It has shown strong efficacy and safety in triple-negative breast cancer models, with potential for broader cancer applications. For more information, please visit Anbogen's official website at View original content: SOURCE Anbogen Therapeutics
